DWTX

Dogwood Therapeutics, Inc. - Common Stock (DWTX)

About Dogwood Therapeutics, Inc. - Common Stock (DWTX)

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Details

Daily high
$1.62
Daily low
$1.46
Price at open
$1.61
52 Week High
$9.50
52 Week Low
$1.28
Market cap
51.8M
Dividend yield
0.00%
Volume
60,141
Avg. volume
59,456
P/E ratio
-.15

Dogwood Therapeutics, Inc. - Common Stock News

Details

Daily high
$1.62
Daily low
$1.46
Price at open
$1.61
52 Week High
$9.50
52 Week Low
$1.28
Market cap
51.8M
Dividend yield
0.00%
Volume
60,141
Avg. volume
59,456
P/E ratio
-.15